5442-12-6
Chemical Structure
(Rac)-Norcantharidin
Synonym(s): (Rac)-NCTD
- CAS No.: 5442-12-6
- Formula:C8H8O4
- Molecular Weight:168.15
IUPAC Name: hexahydro-4,7-epoxyisobenzofuran-1,3-dione
InChIKey: JAABVEXCGCXWRR-UHFFFAOYSA-N
SMILES: O=C1OC(C2C(O3)CCC3C21)=O
Biological Activity: (Rac)-Norcantharidin ((Rac)-NCTD) is the racemic form of Norcantharidin. Norcantharidin is a demethylated derivative of Cantharidin (HY-N0209) and has antitumor activity[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(Rac)-Norcantharidin | 98.0% | (Rac)-Norcantharidin ((Rac)-NCTD) is the racemic form of Norcantharidin. Norcantharidin is a demethylated derivative of Cantharidin (HY-N0209) and has antitumor activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(Rac)-Norcantharidin (Standard) | 93.16% | (Rac)-Norcantharidin (Standard) is the analytical standard of (Rac)-Norcantharidin (HY-N0585). This product is intended for research and analytical applications. (Rac)-Norcantharidin ((Rac)-NCTD) is the racemic form of Norcantharidin. Norcantharidin is a demethylated derivative of Cantharidin (HY-N0209) and has antitumor activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 1.00
HY-N0291R(3aR,4S,7R,7aS)-Hexahydro-4,7-epoxyisobenzofuran-1,3-dione (Standard) -
Similarity Score 0.74
HY-W096183RTandospirone impurity 3 (Standard) -
Similarity Score 0.72
HY-W1029814,10-Dioxatri cyclo[5.2. 1.02.6]dec-8-ene-3,5-dione -
Similarity Score 0.69
HY-W5859424-Methylhexahydroisobenzofuran-1,3-dione -
Similarity Score 0.68
HY-W008293Himic anhydride -
Similarity Score 0.67
HY-W106322Methyl nadic anhydride -
Similarity Score 0.66
HY-113976AREndothall (Standard) -
Similarity Score 0.63
HY-N2501Sodium Demethylcantharidate -
Similarity Score 0.62
HY-N1443Demethylcantharidate disodium -
Explore the MedChemAI to find more analogs
References
- [1]. Pan MS, et al. Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities. Chin Med. 2020 May 29;15:55. [Content Brief]
- [2]. Zhou J, et al. Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years. Biomed Pharmacother. 2020 Nov;131:110755. [Content Brief]
- [3]. Zhang YY, et al. Norcantharidin inhibits the METTL16/MAT2A pathway to induce apoptosis and suppress tumor progression in ovarian cancer. Arch Biochem Biophys. 2025 Sep;771:110510. [Content Brief]